Menlo Ventures has made a $16…
Menlo Ventures has made a $16 million bet that the [...]
Roche has got in on the B7-H3…
Roche has got in on the B7-H3 action, agreeing to [...]
Aktis Oncology exceeded its own…
Aktis Oncology exceeded its own expectations for its IPO in [...]
After netting a $361 million…
After netting a $361 million series C funding round in [...]
After unsheathing just a few…
After unsheathing just a few months ago, Ollin Biosciences’ next-gen [...]
GSK has committed $50 million in…
GSK has committed $50 million in upfront capital and near-term [...]
Tessera Therapeutics is planning…
Tessera Therapeutics is planning to lay off 90 employees, the [...]
Protein degradation biotech…
Protein degradation biotech EpiBiologics has brought in $107 million in [...]
Acuitas Therapeutics shelled out…
Acuitas Therapeutics shelled out an undisclosed sum to acquire a [...]
Novo Nordisk has begun a vital…
Novo Nordisk has begun a vital year for its weight-loss [...]